Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice

ABSTRACT The dynamics of host-pathogen interactions have important implications for the design of new antimicrobial agents to treat chronic infections such as tuberculosis (TB), which is notoriously refractory to conventional drug therapy. In the mouse model of TB, an acute phase of exponential bacterial growth in the lungs is followed by a chronic phase characterized by relatively stable numbers of bacteria. This equilibrium could be static, with little ongoing replication, or dynamic, with continuous bacterial multiplication balanced by bacterial killing. A static model predicts a close correspondence between “viable counts” (live bacteria) and “total counts” (live plus dead bacteria) in the lungs over time. A dynamic model predicts the divergence of total counts and viable counts over time due to the accumulation of dead bacteria. Here, viable counts are defined as bacterial CFU enumerated by plating lung homogenates; total counts are defined as bacterial chromosome equivalents (CEQ) enumerated by using quantitative real-time PCR. We show that the viable and total bacterial counts in the lungs of chronically infected mice do not diverge over time. Rapid degradation of dead bacteria is unlikely to account for the stability of bacterial CEQ numbers in the lungs over time, because treatment of mice with isoniazid for 8 weeks led to a marked reduction in the number of CFU without reducing the number of CEQ. These observations support the hypothesis that the stable number of bacterial CFU in the lungs during chronic infection represents a static equilibrium between host and pathogen.

[1]  G. Middlebrook Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. , 1952, American review of tuberculosis.

[2]  H. M. Vandiviere,et al.  THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*: II. THE DEATH AND RESURRECTION , 1956, The American journal of the medical sciences.

[3]  R. McCune,et al.  FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE , 1956, The Journal of experimental medicine.

[4]  W. Mcdermott,et al.  THE FATE OF MYCOBACTERIUM TUBERCULOSIS IN MOUSE TISSUES AS DETERMINED BY THE MICROBIAL ENUMERATION TECHNIQUE , 1956, The Journal of experimental medicine.

[5]  D. Salkin,et al.  The bacteriology of resected tuberculous pulmonary lesions. I. The effect of interval between reversal of infectiousness and subsequent surgery. , 1956, American review of tuberculosis.

[6]  J. Sever,et al.  Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice. , 1957, American review of tuberculosis.

[7]  R. Rees,et al.  Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. , 1961, British journal of experimental pathology.

[8]  J. Wallace The heat resistance of tubercle bacilli in the lungs of infected mice. , 1961, The American review of respiratory disease.

[9]  Experimental studies on host-parasite equilibrium in tuberculous infection, in relation to vaccination and chemotherapy. , 1966, Japanese journal of medical science & biology.

[10]  W. McDermott Microbial persistence. , 1969, Harvey lectures.

[11]  D. Smith,et al.  Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. , 1970, The American review of respiratory disease.

[12]  I. Orme A mouse model of the recrudescence of latent tuberculosis in the elderly. , 1988, The American review of respiratory disease.

[13]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[14]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[15]  M. Wootton,et al.  The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  T. Wellems,et al.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. , 1997, Microbiology and molecular biology reviews : MMBR.

[17]  I. Orme,et al.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[19]  F. Kramer,et al.  Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis , 1999, Molecular microbiology.

[20]  J. Mckinney In vivo veritas: The search for TB drug targets goes live , 2000, Nature Medicine.

[21]  W. El-Sadr,et al.  A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Donna M. Bouley,et al.  Dynamic Nature of Host-Pathogen Interactions inMycobacterium marinum Granulomas , 2001, Infection and Immunity.

[23]  John Chan,et al.  Tuberculosis: Latency and Reactivation , 2001, Infection and Immunity.

[24]  Yu-Jin Jung,et al.  Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Muñoz-Elías,et al.  Bacterial Persistence: Strategies for Survival , 2002 .

[26]  S. Cole,et al.  Comparative and functional genomics of the Mycobacterium tuberculosis complex. , 2002, Microbiology.

[27]  A. Sher,et al.  Immunology of Infectious Disease , 2002 .

[28]  G. Dougan,et al.  Chronic bacterial infections: living with unwanted guests , 2002, Nature Immunology.

[29]  G. Kaplan,et al.  Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity , 2003, Infection and Immunity.

[30]  I. Orme,et al.  Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .

[31]  Graham R. Stewart,et al.  Tuberculosis: a problem with persistence , 2003, Nature Reviews Microbiology.

[32]  S. Kaufmann,et al.  Cell-wall alterations as an attribute of Mycobacterium tuberculosis in latent infection. , 2003, The Journal of infectious diseases.

[33]  Gilla Kaplan,et al.  Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Ho,et al.  HIV-1 dynamics in vivo: implications for therapy , 2003, Nature Reviews Microbiology.

[35]  Gregory A. Taylor,et al.  Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47 , 2003, Science.

[36]  D. Mitchison,et al.  The search for new sterilizing anti-tuberculosis drugs. , 2004, Frontiers in bioscience : a journal and virtual library.

[37]  J. Pawlotsky Pathophysiology of hepatitis C virus infection and related liver disease. , 2004, Trends in microbiology.

[38]  R. North,et al.  Immunity to tuberculosis. , 2003, Annual review of immunology.